Marlene van den Berg
- Molecular Biology top 2%
- Epidemiology top 10%
- Cell Biology top 5%
- Immunology top 10%
- Physiology top 10%
- Co-authors
- Ben DistelHenk F. TabakEwald H. HettemaChris WilliamsRonald J. A. WandersTineke Voorn-BrouwerYpe ElgersmaCarlo W.T. van Roermund
- Topics
- Peroxisome Proliferator-Activated Receptors (24 papers)RNA Research and Splicing (12 papers)Ubiquitin and proteasome pathways (6 papers)
- Partner nations
- NetherlandsGermanyAustralia
In The Last Decade
Marlene van den Berg
57 papers receiving 3.7k citations
Peers
Comparison fields: 5 of 116
- Molecular Biology 3.1k
- Epidemiology 399
- Cell Biology 397
- Immunology 278
- Physiology 273
Countries citing papers authored by Marlene van den Berg
This map shows the geographic impact of Marlene van den Berg's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Marlene van den Berg with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Marlene van den Berg more than expected).
Fields of papers citing papers by Marlene van den Berg
This network shows the impact of papers produced by Marlene van den Berg. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Marlene van den Berg. The network helps show where Marlene van den Berg may publish in the future.
Co-authorship network of co-authors of Marlene van den Berg
This figure shows the co-authorship network connecting the top 25 collaborators of Marlene van den Berg. A scholar is included among the top collaborators of Marlene van den Berg based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Marlene van den Berg. Marlene van den Berg is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 7 | |
| 2 | 8 | |
| 3 | 19 | |
| 4 | 42 | |
| 5 | 71 | |
| 6 | 33 | |
| 7 | 11 | |
| 8 | 50 | |
| 9 | 178 | |
| 10 | 3 | |
| 11 | 27 | |
| 12 | 108 | |
| 13 | 108 | |
| 14 | 264 | |
| 15 | 14 | |
| 16 | 299 | |
| 17 | 26 | |
| 18 | 18 | |
| 19 | 85 | |
| 20 | 9 |
About Marlene van den Berg
Marlene van den Berg is a scholar working on Clinical Biochemistry, Molecular Biology and Biochemistry, having authored 57 papers that have together received 3.8k indexed citations. Recurring topics across this work include Peroxisome Proliferator-Activated Receptors (24 papers), RNA Research and Splicing (12 papers) and Ubiquitin and proteasome pathways (6 papers). The work is most often cited by research in Molecular Biology (3.1k citations), Biochemistry (242 citations) and Clinical Biochemistry (222 citations). Marlene van den Berg has collaborated with scholars based in Netherlands, Germany and Australia. Frequent co-authors include Ben Distel, Henk F. Tabak, Ewald H. Hettema, Chris Williams, Ronald J. A. Wanders, Tineke Voorn-Brouwer, Ype Elgersma, Carlo W.T. van Roermund, Dominic Hoepfner and Peter Philippsen. Their work appears in journals such as Journal of Biological Chemistry, Journal of Clinical Investigation and Nature Communications.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.